Results 81 to 90 of about 6,457 (148)
peer reviewedBackground: Motor fluctuations are a common complication in later stages of Parkinson's disease (PD) and significantly affect patients' quality of life.
Corvol, J.-C. +7 more
core +1 more source
Introduction: Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, leading to motor and non-motor symptoms that significantly impact patients’ quality of life. Safinamide modulates dopaminergic and glutamatergic systems, offering a promising treatment approach.
Kulisevsky, Jaime +3 more
openaire +5 more sources
Background/Objectives: Advanced Parkinson’s disease is characterized by severe motor fluctuations and disabling dyskinesias that often become refractory to conventional oral dopaminergic therapies.
Károly Orbán-Kis +14 more
doaj +1 more source
Nonmotor fluctuations in Parkinson disease: Severity and correlation with motor complications.
OBJECTIVE: To evaluate frequency, severity, and correlation of nonmotor symptoms (NMS) with motor complications in fluctuating Parkinson disease (PD). METHODS: The Multicenter NonMotor Fluctuations in PD cross-sectional study used clinical examination of
Schneider, Christine B +14 more
core +1 more source
Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations
Levodopa is effective for the motor symptoms of Parkinson's disease (PD), but is associated with motor fluctuations and dyskinesia. Many patients require add-on therapy to improve motor fluctuations without exacerbating dyskinesia.
Pradhan, S +102 more
core +1 more source
Peculiarities of motor fluctuations at different forms of Parkinson's disease
Леводопа є одним з найефективніших препаратів для лікування хвороби Паркінсона. На жаль, на сьогодні ще не знайшли леводопи, яка не має побічного впливу на організм при тривалому використанні. Через декілька років прийому даної терапії у більшості хворих
Таряник, Катерина Анатоліївна +5 more
core
Ami B Patel, Joohi Jimenez-Shahed Department of Neurology, Baylor College of Medicine, Houston, TX, USA Abstract: Inhaled levodopa is a newly emerging therapeutic option in the treatment of “off” symptoms associated with Parkinson ...
Patel AB, Jimenez-Shahed J
doaj
Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson’s disease
Robert A Hauser,1 Aaron Ellenbogen,2 Sarita Khanna,3 Suneel Gupta,3 Nishit B Modi3 1Departments of Neurology, Molecular Pharmacology, and Physiology, University of South Florida, Tampa, FL, USA; 2Quest Research Institute, Bingham Farms, MI, USA; 3Impax ...
Hauser RA +4 more
doaj
Factors associated with the development of motor fluctuations and dyskinesias in parkinson disease
Background Motor fluctuations and dyskinesias can cause disability and reduce quality of life for patients with Parkinson disease (PD). Objectives To evaluate factors associated with the development of motor fluctuations and dyskinesias and to assess
Hauser, Robert A
core
Levodopa in the treatment of Parkinson’s disease: an old drug still going strong
Werner Poewe1, Angelo Antonini2, Jan CM Zijlmans3, Pierre R Burkhard4, François Vingerhoets51Department of Neurology, Medical University of Innsbruck, Austria; 2Parkinson Department, IRCCS San Camillo, Venice, and University of Padua, Italy ...
Werner Poewe +3 more
doaj

